Publication - Advice and guidance

Coronavirus (COVID-19) mRNA vaccine BNT162b2 Pfizer/BioNTech vaccine: national protocol v2.4

This protocol is for the supply and administration of COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech to individuals in accordance with the national COVID-19 vaccination programme. This protocol only allows administration during or in anticipation of COVID-19 pandemic.

Coronavirus (COVID-19) mRNA vaccine BNT162b2 Pfizer/BioNTech vaccine: national protocol v2.4
3. Change history

3. Change history

Version number Change details Date
V01.00 New protocol for COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech vaccine. 21 January 2021
V02.00 Updated protocol to reflect Armed Services staff roles 02 February 2021
V02.1 Clinical Annex updated 22 February 2021
V02.2 Clinical Annex updated 20 April 2021
V02.3 Clinical Annex updated 10 May 2021
V02.4 Clinical Annex updated 24 May 2021

Contact

Email: vaccineoperationaloversight@gov.scot